TEVA Teva Pharmaceutical Industries Limited

NYSE

$39.19

Teva Pharmaceutical Industries Limited (TEVA) Earnings News

Earnings press releases, previews and reviews for Teva Pharmaceutical Industries Limited (TEVA), newest first.

Wednesday September 23, 2026 4:45 PM ET

Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET

Wednesday September 23, 2026 4:45 PM ET

Teva Releases Q3 2026 Aide Memoire

Wednesday July 29, 2026 7:00 AM ET

Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy

Thursday June 18, 2026 5:00 PM ET

Teva Releases Q2 2026 Aide Memoire

Thursday June 18, 2026 4:30 PM ET

Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET

Wednesday April 29, 2026 7:00 AM ET

Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution